首页> 外文会议>National Biomedical Engineering Meeting >Determination of Diffusion Weighted Magnetic Resonance Imaging Based Biomarkers of Mild Cognitive Impairment in Parkinson’s Disease
【24h】

Determination of Diffusion Weighted Magnetic Resonance Imaging Based Biomarkers of Mild Cognitive Impairment in Parkinson’s Disease

机译:基于扩散加权磁共振成像的帕金森病轻度认知障碍生物标志物的确定

获取原文

摘要

This study aims to specify biomarkers of Parkinson's disease mild cognitive impairment (PD-MCI) based on fractional anisotropy (FA) and mean diffusivity (MD) maps obtained from diffusion weighted magnetic resonance imaging (DWMRI). T1 and diffusion weighted MR images collected from 27 cognitively normal Parkinson's disease (PD-CN), 32 mild cognitively impaired Parkinson's disease (PD-MCI), and 18 healthy control (HC) volunteers, at a clinical 3T MR scanner, were processed using FMRIB Software Library (FSL)'s toolboxes. Average regional values of FA and MD maps and tract based spatial statistics (TBSS) were utilized to define statistically significant differences between the participant subject groups.
机译:这项研究的目的是基于分数各向异性(FA)和从弥散加权磁共振成像(DWMRI)获得的平均弥散度(MD)图来指定帕金森氏病轻度认知障碍(PD-MCI)的生物标记物。使用临床3T MR扫描仪处理从27例认知正常帕金森病(PD-CN),32例轻度认知障碍帕金森病(PD-MCI)和18位健康对照(HC)志愿者收集的T1和扩散加权MR图像, FMRIB软件库(FSL)的工具箱。利用FA和MD图的平均区域值以及基于道的空间统计(TBSS)来定义参与者受试者组之间的统计学显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号